Rhumbline Advisers Trims Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Rhumbline Advisers reduced its stake in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 10.4% during the 1st quarter, HoldingsChannel reports. The fund owned 89,633 shares of the company’s stock after selling 10,382 shares during the period. Rhumbline Advisers’ holdings in C4 Therapeutics were worth $143,000 at the end of the most recent […]
Rhumbline Advisers reduced its stake in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 10.4% during the 1st quarter, HoldingsChannel reports. The fund owned 89,633 shares of the company’s stock after selling 10,382 shares during the period. Rhumbline Advisers’ holdings in C4 Therapeutics were worth $143,000 at the end of the most recent […]
